Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1281 - 1288 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC5678 | Pronethalol hydrochloride |
|
<span class='symbol'>β</span>-adrenergic antagonist, clinically effective in the treatment of angina pectoris and some arrhythmias.
|
|
| BCC5679 | GR 46611 |
|
5-HT1D receptor agonist. Blockade of GR 46611-induced hypothermia in the guinea pig provides a useful model with which to study the potency and duration of action of centrally acting 5-HT1D receptor ligands.
|
|
| BCC5680 | m-CPP hydrochloride |
|
5-HT<sub>2C/2B</sub> receptor agonist/partial agonist; displays some activity at 5-HT<sub>2A</sub> and 5-HT<sub>1</sub> receptors. pEC<sub>50</sub> values are 7.09, 7.2, 6.65, 5.9 and 6.5 for human recombinant 5-HT<sub>2C</sub>, <sub>2B</sub> and <sub>2A</sub>, bovine 5-HT<sub>1A</sub> and rat 5-HT<sub>1B</sub> receptors respectively. Suppresses locomotor activity in rats <em>in vivo</em>.
|
|
| BCC5681 | Dihydrexidine hydrochloride |
|
A potent, full efficacy dopamine D1 agonist which shows no agonist activity at peripheral D2 receptors or adrenoceptors at doses which cause maximal stimulation of D1 sites. The compound appears to be fully bioavailable in brain and exhibits profound antiparkinsonism effects in vivo.
|
|
| BCC5682 | RS 45041-190 hydrochloride |
|
Highly selective I2 imidazoline receptor ligand.
|
|
| BCC5683 | Naltriben mesylate |
|
Selective and potent <span class='symbol'>δ</span>-opioid receptor antagonist (K<sub>i</sub> values are 0.013, 19 and 152 nM for <span class='symbol'>δ</span>, <span class='symbol'>μ</span> and <span class='symbol'>κ</span> receptors respectively). Displays selectivity for the <span class='symbol'>δ</span><sub>2</sub> subtype <em>in vivo</em>.
|
|
| BCC5684 | Clocinnamox mesylate |
|
Systemically active, irreversible <span class='symbol'>μ</span>-opioid receptor antagonist (apparent K<sub>i</sub> values are 0.7, 1.9 and 5.7 nM for mouse <span class='symbol'>μ</span>, <span class='symbol'>δ</span> and <span class='symbol'>κ</span> receptors respectively).
|
|
| BCC5685 | MRS 2179 tetrasodium salt |
|
A competitive antagonist at P2Y<sub>1</sub> receptors (K<sub>B</sub> = 100 nM). Selective over P2X<sub>1</sub> (IC<sub>50</sub> = 1.15 <span class='symbol'>μ</span>M), P2X<sub>3</sub> (IC<sub>50</sub> = 12.9 <span class='symbol'>μ</span>M), P2X<sub>2</sub>, P2X<sub>4</sub>, P2Y<sub>2</sub>, P2Y<sub>4</sub> and P2Y<sub>6</sub> receptors. Inhibits the upregulation of NTPDase1 by ATP<span class='symbol'>γ</span>S.
|
|